[1]
Nogueira, M. and Torres, T. 2021. Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis: Focus on Abrocitinib, Baricitinib, and Upadacitinib. Dermatology Practical & Conceptual. (Oct. 2021), e2021145. DOI:https://doi.org/10.5826/dpc.1104a145.